Assessing influenza vaccination success to inform COVID‐19 vaccination campaign
Open Access
- 11 October 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (3) , 918-925
Abstract
Given recent downward trends in daily rates of COVID‐19 vaccinations, it is important to reassess strategies to reach those most vulnerable. The success and efficacy of vaccination campaigns for other respiratory illnesses, such as influenza, may help inform messaging around COVID‐19 vaccinations. This cross‐sectional study examines the individual‐level factors associated with, and the spatial distribution of, predictors of COVID‐19 severity, and uptake of influenza and hepatitis B (as a negative control) vaccines across NYC. Data were obtained from the 2018 Community Health Survey (CHS), including self‐reported influenza and hepatitis B vaccine uptake, diabetes, asthma, hypertension, body mass index (BMI), age, race/ethnicity, educational attainment, borough, and United Hospital Fund (UHF) neighborhood of residence. A CDC‐defined COVID‐19 severity risk score was created with variables available in the CHS, including diabetes, asthma, hypertension, BMI ≥ 30 kg/m2, and age ≥65 years old. After adjustment, there was a significant positive association between COVID‐19 severity risk score and influenza vaccine uptake (1: ORadj = 1.49, 95% CI 1.28–1.73; 2: ORadj = 1.99; 95% CI: 1.65–2.41; 3+: ORadj = 2.89; 95% CI: 2.32–3.60, compared to 0). Hepatitis B vaccine uptake was significantly inversely associated with COVID‐19 severity risk score (1: ORadj = 0.67; 95% CI: 0.57–0.79; 2: ORadj = 0.54; 95% CI: 0.44–0.66; 3+: ORadj = 0.45; 95% CI: 0.36–0.56, compared to 0). The influenza vaccination campaign template is effective at reaching those most at risk for serious COVID‐19 and, if implemented, may help reach the most vulnerable that have not yet been vaccinated against COVID‐19.Keywords
This publication has 21 references indexed in Scilit:
- Disparities in COVID-19 Testing and Positivity in New York CityAmerican Journal of Preventive Medicine, 2020
- Increased vaccine uptake and less perceived barriers toward vaccination in long-term care facilities that use multi-intervention manual for influenza campaignsHuman Vaccines & Immunotherapeutics, 2020
- Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and IncomeAmerican Journal of Preventive Medicine, 2020
- Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 SeasonThe Journal of Infectious Diseases, 2020
- Risk factors of hepatitis B virus infection between vaccinated and unvaccinated groups among spouses in 2006 and 2014: a cross-sectional study in BeijingHuman Vaccines & Immunotherapeutics, 2019
- Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the USVaccine, 2018
- Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015Vaccine, 2018
- Populations at risk for severe or complicated influenza illness: systematic review and meta-analysisBMJ, 2013
- Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in MoroccoBMC Public Health, 2013
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled AnalysisPLOS Medicine, 2011